Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Journal of cancer research and clinical oncology
Year: 2013, Jahrgang: 139, Heft: 12, Pages: 1985-1993 |
| ISSN: | 1432-1335 |
| Online-Zugang: | Verlag, Volltext: http://link.springer.com/article/10.1007%2Fs00432-013-1529-7/fulltext.html
|
| Verfasserangaben: | Hochhaus, Andreas ... Erben, Philipp; Reiter, Andreas ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1472206711 | ||
| 003 | DE-627 | ||
| 005 | 20220811064536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 140312s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00432-013-1529-7 |2 doi | |
| 035 | |a (DE-627)1472206711 | ||
| 035 | |a (DE-576)402206711 | ||
| 035 | |a (DE-599)BSZ402206711 | ||
| 035 | |a (OCoLC)1340635884 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia |b analysis of the phase 2, open-label, single-arm A2101 study |c Hochhaus, Andreas ... Erben, Philipp; Reiter, Andreas ... |
| 264 | 1 | |c 2013 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 12.03.2014 | ||
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 oth | |
| 700 | 1 | |a Erben, Philipp |d 1973- |0 (DE-588)128501014 |0 (DE-627)373920997 |0 (DE-576)297181661 |4 oth | |
| 700 | 1 | |a Reiter, Andreas |d 1964- |0 (DE-588)172629551 |0 (DE-627)697563766 |0 (DE-576)133488594 |4 oth | |
| 773 | 0 | 8 | |i In |t Journal of cancer research and clinical oncology |d Berlin : Springer, 1979 |g 139(2013), 12, Seite 1985-1993 |h Online-Ressource |w (DE-627)253769515 |w (DE-600)1459285-X |w (DE-576)072578319 |x 1432-1335 |7 nnas |a Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia analysis of the phase 2, open-label, single-arm A2101 study |
| 773 | 1 | 8 | |g volume:139 |g year:2013 |g number:12 |g pages:1985-1993 |g extent:9 |a Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia analysis of the phase 2, open-label, single-arm A2101 study |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1007%2Fs00432-013-1529-7/fulltext.html |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20140312 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 172629551 |a Reiter, Andreas |m 172629551:Reiter, Andreas |d 60000 |d 61200 |e 60000PR172629551 |e 61200PR172629551 |k 0/60000/ |k 1/60000/61200/ |p 6 | ||
| 998 | |g 128501014 |a Erben, Philipp |m 128501014:Erben, Philipp |d 60000 |d 61200 |e 60000PE128501014 |e 61200PE128501014 |k 0/60000/ |k 1/60000/61200/ |p 5 | ||
| 999 | |a KXP-PPN1472206711 |e 2786611601 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"oth","given":"Andreas","family":"Hochhaus","display":"Hochhaus, Andreas"},{"display":"Erben, Philipp","family":"Erben","given":"Philipp","role":"oth"},{"family":"Reiter","display":"Reiter, Andreas","role":"oth","given":"Andreas"}],"name":{"displayForm":["Hochhaus, Andreas ... Erben, Philipp; Reiter, Andreas ..."]},"physDesc":[{"extent":"9 S."}],"recId":"1472206711","relHost":[{"title":[{"subtitle":"official organ of the Deutsche Krebsgesellschaft","title_sort":"Journal of cancer research and clinical oncology","title":"Journal of cancer research and clinical oncology"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1979-","publisher":"Springer","dateIssuedKey":"1979"}],"note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia analysis of the phase 2, open-label, single-arm A2101 studyJournal of cancer research and clinical oncology","physDesc":[{"extent":"Online-Ressource"}],"recId":"253769515","id":{"issn":["1432-1335"],"zdb":["1459285-X"],"eki":["253769515"]},"language":["eng","ger"],"titleAlt":[{"title":"Cancer research and clinical oncology"}],"part":{"year":"2013","pages":"1985-1993","issue":"12","text":"139(2013), 12, Seite 1985-1993","extent":"9","volume":"139"}}],"id":{"doi":["10.1007/s00432-013-1529-7"],"eki":["1472206711"]},"note":["Gesehen am: 12.03.2014"],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"title":[{"title":"Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia","title_sort":"Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia","subtitle":"analysis of the phase 2, open-label, single-arm A2101 study"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a EFFECTOFTH2013 | ||